Description
N/A
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.0 - 0.0
Trade Value (12mth)
N/A
1 week
0%
1 month
75%
YTD
-53.33%
1 year
-61.11%
All time high
N/A
EPS 3 yr Growth
N/A
EBITDA Margin
N/A
Operating Cashflow
N/A
Free Cash Flow Return
N/A
ROIC
N/A
Interest Coverage
N/A
Quick Ratio
N/A
Shares on Issue (Fully Dilluted)
N/A
HALO Sector
Healthcare
Next Company Report Date
N/A
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
N/A
Short Sell (% of issue)
N/A
Date | Announcements |
---|---|
31 October 23 |
Quarterly Activity and Cashflow Report
×
Quarterly Activity and Cashflow Report |
31 October 23 |
Calmer Co International Limited - Quarterly Activity and Cashflow Report (CCO-AU)
×
Calmer Co International Limited - Quarterly Activity and Cashflow Report (CCO-AU) |
31 July 23 |
Rights Issue Oversubscribed
×
Rights Issue Oversubscribed |
31 August 23 |
Appendix 4E - Preliminary Final Report
×
Appendix 4E - Preliminary Final Report |
31 August 23 |
Annual Report to shareholders
×
Annual Report to shareholders |
31 August 23 |
Appendix 4G
×
Appendix 4G |
31 August 23 |
Annual Report 2023 - Results Presentation
×
Annual Report 2023 - Results Presentation |
31 August 23 |
Calmer Co International Limited - Appendix 4E - Preliminary Final Report (CCO-AU)
×
Calmer Co International Limited - Appendix 4E - Preliminary Final Report (CCO-AU) |
31 August 23 |
Calmer Co International Limited - Annual Report to shareholders (CCO-AU)
×
Calmer Co International Limited - Annual Report to shareholders (CCO-AU) |
31 August 23 |
Calmer Co International Limited - Appendix 4G (CCO-AU)
×
Calmer Co International Limited - Appendix 4G (CCO-AU) |
31 August 23 |
Calmer Co International Limited - Annual Report 2023 - Results Presentation (CCO-AU)
×
Calmer Co International Limited - Annual Report 2023 - Results Presentation (CCO-AU) |
29 November 23 |
Metagenics USA launches MetaSleep powered by Kavaton
×
Metagenics USA launches MetaSleep powered by Kavaton |
29 November 23 |
Metagenics USA launches Metasleep with Kavaton - Amended
×
Metagenics USA launches Metasleep with Kavaton - Amended |
29 November 23 |
Calmer Co International Limited - Metagenics USA launches MetaSleep powered by Kavaton (CCO-AU)
×
Calmer Co International Limited - Metagenics USA launches MetaSleep powered by Kavaton (CCO-AU) |
29 November 23 |
Calmer Co International Limited - Metagenics USA launches Metasleep with Kavaton - Amended (CCO-AU)
×
Calmer Co International Limited - Metagenics USA launches Metasleep with Kavaton - Amended (CCO-AU) |
29 June 23 |
Update - Proposed issue of securities - CCO
×
Update - Proposed issue of securities - CCO |
28 June 23 |
Entitlement Issue Prospectus
×
Entitlement Issue Prospectus |
28 June 23 |
Proposed issue of securities - CCO
×
Proposed issue of securities - CCO |
28 June 23 |
Rights Issue Underwriting and Shortfall Allocation Policy
×
Rights Issue Underwriting and Shortfall Allocation Policy |
28 June 23 |
Proposed issue of securities - CCO
×
Proposed issue of securities - CCO |
28 July 23 |
Quarterly Activity and Cashflow Report
×
Quarterly Activity and Cashflow Report |
28 April 23 |
Quarterly Activity and Cashflow Report
×
Quarterly Activity and Cashflow Report |
25 July 23 |
Leilo Global Distribution Partnership
×
Leilo Global Distribution Partnership |
24 October 23 |
Fiji Kava Launches in China on Alibaba's Tmall
×
Fiji Kava Launches in China on Alibaba's Tmall |
24 October 23 |
Calmer Co International Limited - Fiji Kava Launches in China on Alibaba's Tmall (CCO-AU)
×
Calmer Co International Limited - Fiji Kava Launches in China on Alibaba's Tmall (CCO-AU) |
23 October 23 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
23 October 23 |
Annual General Meeting - Letter to Shareholders
×
Annual General Meeting - Letter to Shareholders |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.